09.07.2024 13:40:55 - dpa-AFX: *PRELUDE ANNOUNCES CLINICAL COLLABORATION WITH MERCK TO EVALUATE PRT3789 WITH KEYTRUDA IN SMARCA4-MUTATED CANCERS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Merck & Co A0YD8Q NYSE 115,160 30.07.24 20:07:55 -12,620 -9,88% 115,150 115,170 125,775 127,780

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH